FTII FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp.

Blank Checks

Finance

FutureTech II Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus its search on companies in the technology industry. The company was incorporated in 2021 and is based in New Rochelle, New York.

IPO Year: 2022

Exchange: NASDAQ

Recent Analyst Ratings for FutureTech II Acquisition Corp.

Date	Price Target	Rating	Analyst

See more ratings

FutureTech II Acquisition Corp. Press Releases

Fastest customizable press release news feed in the world

View All

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the "Company") (NASDAQ:FTII), today announced that it received an expected deficiency notification letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") on November 27, 2024 (the "Notice"). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the "Q3 10-Q"), as described more fully in the Company's Form 12b-25 Notification of Late Filing filed with the Securities and Exchange Commission (the "SEC") on November 15, 2024. Th

12/4/24 1:35:00 PM ET

$FTII

Blank Checks

Finance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of longevity-related products and services designed to increase the health span for the rapidly growing global aging population. -Late-stage, diversified pipeline of therapeutic candidates across ophthalmology, cardiovascular disease and soft tissue reconstruction and repair. -Near-term clinical milestones include Phase 3 start for LBI-201 for Ischemic stroke, Phase 2 data for LBI-101 for soft-tissue reconstruction, and Phase 2 start for LBI-001 in retinal vein occlusion. -Seasoned management team of m

9/20/24 2:55:00 PM ET

$FTII

Blank Checks

Finance

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (NASDAQ:FTIIU) (the "Company"), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, announced today that it caused to be deposited $1,150,000 into the Company's trust account for its public stockholders, representing $0.10 per public share, allowing the Company to extend by three months (from May 18, 2023 to August 18, 2023) the period of time the Company has to consummate its initial business combination (the "Extension"). The Extension is the second of two

5/17/23 4:05:00 PM ET

$FTII

Blank Checks

Finance

FutureTech II Acquisition Corp.

Recent Analyst Ratings for FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp.

Recent Analyst Ratings for FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. Press Releases

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Insider Trading

CEO & CFO Chen Ray Lei converted options into 380,000 shares (SEC Form 4)

Large owner Radu Zachary C. converted options into 2,445,000 shares (SEC Form 4)

Director Bush Neil converted options into 10,000 shares (SEC Form 4)

Director Moseley Jeffrey Alan converted options into 10,000 shares (SEC Form 4)

Former director of the board Zutshi Aroop converted options into 10,000 shares (SEC Form 4)

Former CFO, Former director Greenall Michael William converted options into 20,000 shares (SEC Form 4)

Large owner Futuretech Partners Ii Llc converted options into 2,445,000 shares, increasing direct ownership by 470% to 2,965,075 units (SEC Form 4)

New insider Radu Zachary C. claimed ownership of 520,075 shares (SEC Form 3)

Wang Yuquan disposed of 520,075 shares (SEC Form 4)

SEC Form 3 filed by new insider Mckeage Jonathan F

FutureTech II Acquisition Corp. SEC Filings

SEC Form 10-Q filed by FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

FutureTech II Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

SEC Form NT 10-Q filed by FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

SEC Form DEF 14A filed by FutureTech II Acquisition Corp.

SEC Form PRE 14A filed by FutureTech II Acquisition Corp.

SEC Form 25-NSE filed by FutureTech II Acquisition Corp.

SEC Form 10-Q filed by FutureTech II Acquisition Corp.

SEC Form NT 10-Q filed by FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. Large Ownership Changes

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

SEC Form SC 13G filed by FutureTech II Acquisition Corp.

Amendment: SEC Form SC 13G/A filed by FutureTech II Acquisition Corp.

SEC Form SC 13G filed by FutureTech II Acquisition Corp.

SEC Form SC 13G/A filed by FutureTech II Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by FutureTech II Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by FutureTech II Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by FutureTech II Acquisition Corp. (Amendment)

SEC Form SC 13G/A filed by FutureTech II Acquisition Corp. (Amendment)